TY - JOUR
T1 - The Schizophrenia Patient Outcomes Research Team (PORT)
T2 - Updated treatment recommendations 2003
AU - Lehman, Anthony F.
AU - Kreyenbuhl, Julie
AU - Buchanan, Robert W.
AU - Dickerson, Faith B.
AU - Dixon, Lisa B.
AU - Goldberg, Richard
AU - Green-Paden, Lisa D.
AU - Tenhula, Wendy N.
AU - Boerescu, Daniela
AU - Tek, Cenk
AU - Sandson, Neil
AU - Steinwachs, Donald M.
PY - 2004
Y1 - 2004
N2 - Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations in 1998, considerable scientific advances have occurred in our knowledge about how to help persons with schizophrenia. Today an even stronger body of research supports the scientific basis of treatment. This evidence, taken in its entirety, points to the value of treatment approaches combining medications with psychosocial treatments, including psychological interventions, family interventions, supported employment, assertive community treatment, and skills training. The most significant advances He in the increased options for pharmacotherapy, with the introduction of second generation antipsychotic medications, and greater confidence and specificity in the application of psychosocial interventions. Currently available treatment technologies, when appropriately applied and accessible, should provide most patients with significant relief from psychotic symptoms and improved opportunities to lead more fulfilling lives in the community. Nonetheless, major challenges remain, including the need for (1) better knowledge about the underlying etiologies of the neurocognitive impairments and deficit symptoms that account for much of the disability still associated with schizophrenia; (2) treatments that more directly address functional impairments and that promote recovery; and (3) approaches that facilitate access to scientifically based treatments for patients, the vast majority of whom currently do not have such access.
AB - Since publication of the original Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations in 1998, considerable scientific advances have occurred in our knowledge about how to help persons with schizophrenia. Today an even stronger body of research supports the scientific basis of treatment. This evidence, taken in its entirety, points to the value of treatment approaches combining medications with psychosocial treatments, including psychological interventions, family interventions, supported employment, assertive community treatment, and skills training. The most significant advances He in the increased options for pharmacotherapy, with the introduction of second generation antipsychotic medications, and greater confidence and specificity in the application of psychosocial interventions. Currently available treatment technologies, when appropriately applied and accessible, should provide most patients with significant relief from psychotic symptoms and improved opportunities to lead more fulfilling lives in the community. Nonetheless, major challenges remain, including the need for (1) better knowledge about the underlying etiologies of the neurocognitive impairments and deficit symptoms that account for much of the disability still associated with schizophrenia; (2) treatments that more directly address functional impairments and that promote recovery; and (3) approaches that facilitate access to scientifically based treatments for patients, the vast majority of whom currently do not have such access.
KW - Mental health services
KW - Pharmacotherapy
KW - Psychosocial treatment
KW - Quality of care
KW - Schizophrenia
KW - Treatment outcomes
UR - http://www.scopus.com/inward/record.url?scp=1542270909&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542270909&partnerID=8YFLogxK
U2 - 10.1093/oxfordjournals.schbul.a007071
DO - 10.1093/oxfordjournals.schbul.a007071
M3 - Review article
C2 - 15279040
AN - SCOPUS:1542270909
SN - 0586-7614
VL - 30
SP - 193
EP - 217
JO - Schizophrenia bulletin
JF - Schizophrenia bulletin
IS - 2
ER -